Taking stock of the drug industry, from the lab to the medicine chestApril 24, 2023Check out STAT+Sponsored ByBy Ed SilvermanPharmalot Columnist, Senior Writer Sean Gallup/Getty Images STAT+ | 'A tug of war': Europe braces for new legislation with far-reaching impacts on pharma and patients The European Commission will soon release long-awaited draft legislation on drug pricing, patent exclusivity, access, and more. By Ed Silverman and Andrew Joseph STAT+ | Maryland pushes first-of-its-kind bill to promote alternatives to animals in biomedical research Maryland is on the verge of becoming the first state to adopt a law that would make a dedicated investment in alternative approaches. By Ed Silverman STAT+ | Bluebird submits sickle cell gene therapy to FDA for approval The filing sets up a competition with Vertex Pharmaceuticals and CRISPR Therapeutics, which previously filed with the FDA. By Allison DeAngelis SIA KAMBOU/AFP via Getty Images) Opinion: How small vaccine stockpiles can stop outbreaks of infectious disease from becoming big The strategic use of relatively small vaccine stockpiles to stamp out outbreaks quickly is likely to become increasingly important By Seth Berkley Opinion: How journalists can cover RFK Jr.'s antivax presidential run responsibly Seven things that the media should do to cover RFK Jr. without accidentally spreading anti-vaccine disinformation. By Leah Russin More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments